Research

March 26, 2024

GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes

The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin.
(Adobestock)
March 26, 2024

Beethoven’s genes reveal low predisposition for beat synchronization

What the exceptional composer’s DNA tells us about genetics

By Craig Boerner
March 25, 2024

Brain atlas pinpoints vulnerabilities in ALS and dementia

By Paul Govern
(iStock image)
March 25, 2024

VUMC team finds potential treatment for kidney fibrosis

By Bill Snyder
Participants in the Genetic Counseling Research Symposium were (back row from left) Lucas Richter, MM, CGC, Fellowship in Genomics Outcomes Research, (FIGOR); and Mikaela Bradley, Makenna Martin, Cecilia Kessler, and Joan Kornkven, Master’s in Genetic Counseling degree program, Class of 2024, (front row from) left, Mary Hurley, Class of 2024; Jill Slamon, MA, MS, CGC, Advanced Research Training for Genetic Counselors certificate program; Toni Lewis, MS, FIGOR; Lianna Paul, and Serena Fleming, Class of 2024; and MGC program director Martha Dudek, MS, CGC. (photo by Susan Urmy)
March 12, 2024

Genetic Counseling Research Symposium debuts on April 5

The Master of Genetic Counseling degree program at Vanderbilt University School of Medicine will hold its first Genetic Counseling Research Symposium April 5 from 8 a.m. to 6 p.m. in room 202, Light Hall.

By Bill Snyder
March 11, 2024

Phase 3 CELLEBRATE trial testing regenerative stem cell-based therapy to improve urinary control for women

The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. 

By Craig Boerner
March 7, 2024

Study details metabolism of biomarkers for oxidative stress

Factors other than oxidative stress can modify the levels of biomarkers called isoprostanes that are commonly used in both experimental and clinical research, suggesting that additional standards need to be developed.
By Leigh MacMillan
March 7, 2024

Blood mutations increase risk for acute kidney injury: study

A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide.
By Bill Snyder
March 4, 2024

Dame Frances Ashcroft to deliver March 21 Vanderbilt Prize Lecture

Professor Dame Frances Ashcroft, recipient of the 2023 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. Thursday, March 21, in 208 Light Hall.
By Bill Snyder
February 27, 2024

Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment

Multi-institutional study finds that enrollment and outcomes were similar across various groups of children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide.
By Leigh MacMillan
February 22, 2024

AI aids efforts to cut nuisance alerts for health care teams: study

A new study from Vanderbilt University Medical Center demonstrates the promise of artificial intelligence to help refine and target the myriad computerized alerts intended to assist doctors and other team members in day-to-day clinical decision-making.
By Paul Govern
February 21, 2024

International genetic study of glaucoma implicates vascular and cancer-related genes

An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.
By Leigh MacMillan
February 19, 2024

VUMC part of major step to achieving precision medicine

An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.
By Bill Snyder
1 … 22 23 24 25 26 … 135